Fantini, M., Tsang, K. Y., & Arlen, P. M. (2024). Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells. Taylor & Francis Group.
Chicago Style (17th ed.) CitationFantini, Massimo, Kwong Y. Tsang, and Philip M. Arlen. Generation of the Therapeutic Monoclonal Antibody NEO-201, Derived from a Cancer Vaccine, Which Targets Human Malignancies and Immune Suppressor Cells. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationFantini, Massimo, et al. Generation of the Therapeutic Monoclonal Antibody NEO-201, Derived from a Cancer Vaccine, Which Targets Human Malignancies and Immune Suppressor Cells. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.